3636 — Mitsubishi Research Institute Balance Sheet
0.000.00%
- ¥71bn
- ¥65bn
- ¥115bn
- 89
- 71
- 88
- 96
Annual balance sheet for Mitsubishi Research Institute, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 32,738 | 29,397 | 33,157 | 25,226 | 30,927 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13,596 | 17,734 | 38,074 | 42,775 | 40,577 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 56,028 | 59,142 | 73,921 | 71,154 | 74,282 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,625 | 11,310 | 10,659 | 12,114 | 10,937 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 96,253 | 99,704 | 114,652 | 118,009 | 119,732 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19,228 | 20,618 | 30,239 | 30,777 | 31,128 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 42,395 | 43,425 | 51,600 | 52,208 | 52,101 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 53,858 | 56,279 | 63,052 | 65,801 | 67,631 |
Total Liabilities & Shareholders' Equity | 96,253 | 99,704 | 114,652 | 118,009 | 119,732 |
Total Common Shares Outstanding |